ClinicalTrials.Veeva

Find clinical trials for Non-Hodgkin Lymphoma in San Antonio, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Lymphoma
B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Leukemia
Lymphoid Leukemia
B-Cell Chronic Lymphocytic Leukemia
Mantle-Cell Lymphoma

Non-Hodgkin Lymphoma trials near San Antonio, TX, USA:

Tisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma (BELINDA)

to Standard Of Care in adult patients with aggressive B-cell Non-Hodgkin Lymphoma after failure of rituximab and anthracyc...

Active, not recruiting
Non-Hodgkin Lymphoma
Drug: Tisagenlecleucel after optional bridging and lymphodepleting chemotherapy
Drug: Platinum-based immunochemotherapy followed in responding patients with high dose chemotherapy and autologous hematopoietic stem cell transplant (HSCT)

Phase 3

Novartis
Novartis

San Antonio, Texas, United States and 66 other locations

and young adult participants with recurrent or refractory classical Hodgkin lymphoma and non-Hodgkin lymphoma...

Enrolling
Hodgkin Disease
Lymphoma, Non-Hodgkin
Drug: Relatlimab
Drug: Nivolumab

Phase 1, Phase 2

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

San Antonio, Texas, United States and 72 other locations

Part 1: To characterize the safety profile of acalabrutinib alone or in combination with rituximab in subjects with R/R FL.Part 2: To characterize th...

Active, not recruiting
Non Hodgkin Lymphoma
Drug: acalabrutinib
Drug: rituximab (IV)

Phase 1

Acerta Pharma
Acerta Pharma

San Antonio, Texas, United States and 31 other locations

patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or Non-Hodgkin's Lymphomas wh...

Active, not recruiting
Non-Hodgkin's Lymphoma
Small Lymphocytic Lymphoma
Drug: CG-806

Phase 1

Aptose Biosciences

San Antonio, Texas, United States and 29 other locations

in participants with relapsed or refractory (R/R) solid tumors or non-Hodgkin lymphoma (NHL).Part 2: Cohort Expansion. The...

Enrolling
Non-Hodgkin Lymphoma
Relapsed Solid Tumors
Drug: KB-0742

Phase 1, Phase 2

Kronos Bio

San Antonio, Texas, United States and 25 other locations

targeting both cluster of differentiation (CD) CD19 and CD20 for the treatment of adult participants with relapsed or refractory B-Cell non- ...

Enrolling
Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
Biological: JNJ-90014496

Phase 1

Janssen
Janssen

San Antonio, Texas, United States and 7 other locations

Phase 1, open-label, multicenter study of WTX-330 administered as a monotherapy to patients with advanced or metastatic solid tumors or non- ...

Enrolling
Non-Hodgkin Lymphoma
Advanced or Metastatic Solid Tumors
Drug: WTX-330

Phase 1

Werewolf Therapeutics

San Antonio, Texas, United States and 8 other locations

This is an open-label, multicenter, first-in-human phase I/II study which is composed of 3 parts: phase I dose escalation, phase I dose extension and...

Enrolling
Non-Hodgkin's Lymphoma, Relapsed
Non-Hodgkin's Lymphoma Refractory
Drug: HH2853 Tablets

Phase 1, Phase 2

Haihe Biopharma

San Antonio, Texas, United States and 12 other locations

according to the Lugano Classification of response in malignant lymphoma (Cheson, 2014) and as assessed by independent central review in eac-...

Enrolling
B-cell Non-Hodgkin Lymphoma (NHL)
Drug: Odronextamab

Phase 2

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Fort Sam Houston, Texas, United States and 137 other locations

This is an open-label, multicenter, Phase 1/2 study evaluating the safety and efficacy of CTX112™ in subjects with relapsed or refractory B-cell mali...

Enrolling
Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Marginal Zone Lymphoma
Biological: CTX112

Phase 1, Phase 2

CRISPR Therapeutics

San Antonio, Texas, United States and 1 other location

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems